Mendel Suchmacher

Mendel Suchmacher

Auto-generated profile, based on publicly available information

Mendel Suchmacher

Postgraduate Program in Immunology, Instituto de Pós-graduação Médica Carlos Chagas, Rio de Janeiro, RJ, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in Current Therapeutic Research
Verified
Journal Article
Open access
CNCarlos P. Nunes
Carlos P. Nunes
CRClaudio Rodrigues
Claudio Rodrigues
MSMendel Suchmacher
Mendel Suchmacher
CEClaudia Regina Esteves
Claudia Regina Esteves
KGKarin Gonçalves
Karin Gonçalves
MGMauro Geller
Mauro Geller
Motion sickness (kinetosis) is a common and temporarily incapacitant ailment, manageable with behavioral as well as pharmacological measures. To assess the effectiveness and safety of a combination of gamma-aminobutyric acid, glutamic acid, calcium, thiamine, pyridoxine, and cyanocobalamin (Group A) (n = 170) and extract of Zingiber officinale (ginger) (Group B) (n = 165) in the management of chronic complaints consistent with motion sickness. Both groups were tested according to the following end points, under self-paired as well as comparative study designs: reduction of ≥20 score points in the total motion sickness assessment questionnaire (MSAQ) score, percentage of patients presenting a reduction of the total MSAQ score, absolute MSAQ score reduction, physician's assessment scores, final overall assessment of study medication, and willingness to continue treatment. Safety was also evaluated. There was a statistically significant better performance under both study designs for Group A (P = 0.05 using different statistical tests) in all end points. Both regimens were safe, with different neurological and gastrointestinal tolerability outcomes. Group A and Group B regimens were effective and safe in the management of chronic complaints consistent with motion sickness and the Group A regimen was more effective than Group B.

1 April 2025 in Revista Brasileira de Ortopedia
Verified
Journal Article
Open access
PDF file
MMMarco Antonio N. Mibielli
Marco Antonio N. Mibielli
MSMendel Suchmacher
Mendel Suchmacher
MGMauro Geller
Mauro Geller
SMSpyros G. E. Mezitis
Spyros G. E. Mezitis
CNCarlos P. Nunes
Carlos P. Nunes
ASAline Sintoveter
Aline Sintoveter
Low back pain is a common complaint. This syndrome comprehends different underlying mechanisms, which are difficult to differentiate in a timely manner only through semiotic, laboratory, and imaging resources available in an emergency setting. Such circumstances make practitioners prone to an initial symptomatic approach in the form of medications (non-steroid anti-inflammatory drugs, analgesics, muscle relaxants) or local procedures (local heat, massage). Peripheral neurotrophic substances, such as pyrimidine nucleotides (uridine triphosphate and cytidine monophosphate) combined with vitamin B12 (hydroxocobalamin), have been used as anabolic precursors able to provide spinal nerve roots with triggering elements useful for nerve and glial cells regeneration, once a likely spinal compression mechanism is contained. The authors performed a systematic review and meta-analysis with the above combination with the aim of better determining its role in low back pain management.

10 December 2021 in Revista de Medicina
Verified
Journal Article
Open access
PDF file
VAVitoria Azulay
Vitoria Azulay
MSMendel Suchmacher
Mendel Suchmacher
ILIbson Lucas de Lyra
Ibson Lucas de Lyra
GFGustavo Robertson Filippo
Gustavo Robertson Filippo
A neurofibromatose tipo I é uma doença autossômica dominante cujo diagnóstico é feito com base em critérios clínicos. As três principais manifestações: neurofibromas, manchas café com leite e nódulos de Lisch ocorrem em mais de 90% dos pacientes até a puberdade. Relatamos o caso de uma paciente jovem com diagnóstico de neurofibromatose tipo I com complicações ortopédicas devido à elefantíase causada por um neurofibroma plexiforme.

1 April 2025 in Revista Brasileira de Ortopedia
Verified
Journal Article
Open access
PDF file
MMMarco Antonio N. Mibielli
Marco Antonio N. Mibielli
MSMendel Suchmacher
Mendel Suchmacher
MGMauro Geller
Mauro Geller
SMSpyros G. E. Mezitis
Spyros G. E. Mezitis
CNCarlos P. Nunes
Carlos P. Nunes
ASAline Sintoveter
Aline Sintoveter
Resumo: A dor lombar é uma queixa comum. Essa síndrome tem diferentes mecanismos subjacentes, difíceis de diferenciar em tempo hábil apenas por meio dos recursos semióticos, laboratoriais e de imagem disponíveis no atendimento de emergência. Isso faz com que os profissionais tendam a uma abordagem sintomática inicial composta por medicamentos (anti-inflamatórios não esteroidais, analgésicos, relaxantes musculares) ou procedimentos locais (calor local, massagem). Substâncias neurotróficas periféricas, como nucleotídeos de pirimidina (trifosfato de uridina e monofosfato de citidina) combinados com vitamina B12 (hidroxicobalamina), têm sido usadas como precursores anabólicos capazes de fornecer às raízes nervosas espinhais elementos desencadeadores úteis para a regeneração de neurônios e células da glia, uma vez que um provável mecanismo de compressão espinhal seja contido. Os autores realizaram uma revisão sistemática e meta-análise com a combinação acima com o objetivo de determinar melhor seu papel no tratamento da dor lombar.